Digestive System Diseases

633 trials 301 recruiting

Filter these 633 trials by phase, country and sponsor.

Open in Search →

Adipose-derived mesenchymal stem cells as local treatment of ulcerative colitis Ended

2024-518643-38-00 ulcerative colitis 9 2023-06-30
Drug-Drug Interaction Study With AGMB-129 and Midazolam in Healthy Participants Ended

2023-504461-23-00 Fibrostenotic Crohn’s disease 3 2023-06-26
A Phase I, Single-Centre, Double-Blind, Randomized, Placebo-Controlled Clinical Trial To Determine Urinary Xylose Cut-Off Point For The Diag… Ended

2023-504232-18-00 Hypolactasia 3 2023-06-22
A Single Dose, Fast State, Bioequivalence Study of CEFIXIMA ATB 400 mg Hard Capsules (Antibiotice S.A.) vs. CEFIXORAL® 400 mg Film Coated Ta… Ended

2023-504011-33-00 healthy subjects 2 2023-06-12
ABTECT-1 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -1 Ended

2022-500535-36-01 Moderately to severely active ulcerative colitis 5 2023-06-12
ABTECT-2 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -2 Ended

2022-500536-11-01 Moderately to severely active ulcerative colitis 5 2023-06-08
A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Camizestrant in Post-menopausal … Ended

2022-502277-41-00 moderate or severe hepatic impairment 3 2023-06-05
A Phase 2, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus … Ended

2022-500177-13-00 Metastatic Colorectal Cancer (mCRC) 4 2023-06-02
A Phase 1b, 2-part, placebo-controlled study to evaluate the efficacy, safety, and PK of PF-07054894 in participants with mild to severe UC. Ended

2022-501047-32-00 ULCERATIVE COLITIS 3 2023-05-30
A Randomized, Open-label, Single Dose, 3-Period, 6-Sequence Cross-Over Trial to Investigate the Relative Bioavailability of Apraglutide Vers… Ended

2023-504430-22-00 Healthy 2 2023-05-23
Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Oral Ozanimod in Pediatric Participants with Moderately to Severely Active Crohn… Ended

2023-508777-91-00 Moderately to Severely Active Crohn's Disease 10 2023-05-16
Menthacarin® in the treatment of functional gastrointestinal disorders Ended

2022-501800-92-00 functional gastrointestinal disorders 6 2023-05-15
Study to Evaluate the Safety, Pharmacokinetics, and Dose Response of Paltusotine Treatment in Subjects with Carcinoid Syndrome Ended

2024-511922-30-00 Carcinoid Syndrome 4 2023-05-11
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202 in Patients with Mild-to-Moderate Ulcerative Colitis Ended

2024-512558-40-00 Mild-to-moderate ulcerative colitis 4 2023-05-11
Phase IV comparative, randomized, open-label pilot study to evaluate the efficacy and safety of a rilpivirine-based antiretroviral treatment… Ended

2022-503110-23-00 Metabolic liver disease in HIV-infected people 6 2023-05-05
A Phase 1 Study Evaluating Relative Bioavailability of Sprinkled Ritlecitinib in Applesauce, Yoghurt, and Strawberry Jam and Evaluating the … Ended

2022-502872-22-00 Alopecia Areata, Rheumatoid Arthritis, Vitiligo, Ulcera 3 2023-04-28
Primary carE PPi dEprescRibing (PEPPER) trial Ended

2022-502375-37-00 heartburn 6 2023-04-16
Phase 2b Study of GSK4532990 in Adults with NASH (HORIZON) Ended

2023-507503-62-00 Non-alcoholic Fatty Liver Disease 4 2023-03-30
Phase 1b study investigating the association of NP137 with mFOLFIRINOX in locally advanced pancreatic ductal adenocarcinoma LAP NET 1 Ended

2022-500905-42-00 pancreatic ductal adenocarcinoma 3 2023-03-24
A Phase 1 Study to Evaluate the Safety and Target Engagement of EXL01 in the Maintenance of Steroid-induced Clinical Response or Remission … Ended

2022-502241-99-00 Crohn's Disease 1 2023-03-20
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn’s Disease Ended

2024-511089-36-00 Crohn’s disease 4 2023-03-17
A phase IIa, open label, Single-centre study to assess the initial antifibrotic efficacy, safety, tolerability, pharmacokinetic and pharmaco… Ended

2022-501464-18-00 Crohn’s disease 4 2023-03-01
Clinical investigation evaluating safety and efficacy of selective intra-arterial 166Holmium radiation therapy in combination with atezolizu… Ended

2024-511538-11-00 Non resectable Hepatocellular carcinoma (HCC) 4 2023-02-07
Evaluation of the value of perianal infiltration during thermodestruction of hemorrhoidal disease by Radiofrequency (RAFAELO® procedure) Ended

2024-514117-35-00 hemorrhoidal disease 11 2023-01-10